Cronos Group (NASDAQ:CRON) Sets New 12-Month Low – Should You Sell?

Cronos Group Inc. (NASDAQ:CRON)’s share price reached a new 52-week low on Monday . The stock traded as low as $1.83 and last traded at $1.84, with a volume of 92246 shares changing hands. The stock had previously closed at $1.90.

Cronos Group Trading Up 1.6 %

The company’s fifty day simple moving average is $1.98 and its two-hundred day simple moving average is $2.13.

Institutional Investors Weigh In On Cronos Group

A number of hedge funds and other institutional investors have recently modified their holdings of CRON. Thompson Davis & CO. Inc. bought a new stake in Cronos Group in the fourth quarter worth about $29,000. Quantbot Technologies LP purchased a new position in shares of Cronos Group during the third quarter valued at $37,000. International Assets Investment Management LLC increased its holdings in shares of Cronos Group by 119.0% in the 3rd quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after purchasing an additional 22,628 shares during the period. Barclays PLC purchased a new stake in Cronos Group in the 3rd quarter worth approximately $97,000. Finally, Virtu Financial LLC boosted its position in Cronos Group by 242.7% during the third quarter. Virtu Financial LLC now owns 54,516 shares of the company’s stock valued at $119,000 after purchasing an additional 38,607 shares during the last quarter. 8.71% of the stock is currently owned by institutional investors.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.